LLY
Eli Lilly and Company Canadian Depositary Receipt · TSX:LLY
50.51 CAD1.62 +3.31%
Eli Lilly and Company Canadian Depositary Receipt (TSX:LLY) last traded at 50.51 CAD, up 3.31% on the day. Over the past year the stock is up 31.71%. Its 52-week range is 30.67 to 51.66. It is in the Health Technology sector (Pharmaceuticals: Major).
Key statistics
Open50.27
Day range50.20 – 51.66
52-week range30.67 – 51.66
Volume170.78 K
Average volume (10 days)106.69 K
Market cap (USD)1.33 T
P/E43.86
EPS (TTM) (USD)0.8088
Dividend yield0.48%
Beta (1 year)0.9211
Revenue (TTM) (USD)84.29 B
Employees50.00 K
Performance
+8.37%1 week
+19.32%1 month
+22.30%3 months
+48.47%6 months
+29.25%Year to date
+31.71%1 year
Technical reading
Strongly bullish
Daily summary of what 11 oscillators and 15 moving averages show. See every indicator
Latest headlines
- Cathie Wood's weekly recap: loads TER, AVAV after strong results; books gain in AMD, TSM, LLYSeeking Alpha · 02 Nov 2026
- Notable healthcare headlines for the week: Eli Lilly, Merck, and AstraZeneca in focusSeeking Alpha · 01 Nov 2026
- Healthcare sector rallies in October amid rotation away from technology stocksSeeking Alpha · 31 Oct 2026
- Healthcare Earnings Scoreboard: 96% beat EPS estimates, 70% post Y/Y earnings growthSeeking Alpha · 31 Oct 2026
- Elon Musk Says Eli Lilly Has ‘Some Banger Drugs Coming Out’ After CEO Dave Ricks Bets Against Vinod Khosla's Big Biotech SkepticismBenzinga · 31 Oct 2026
- Cathie Wood Loads Up On TEM, ILMN And Biotech Stocks — But Pares Stake In This Pharma Giant That Had A Blowout Q3Stocktwits · 31 Oct 2026
- Eli Lilly Is Maintained at Buy by UBSDow Jones Newswires · 31 Oct 2026
- UBS maintains Eli Lilly at Buy, raises price target to $1625 from $1425TradingView · 31 Oct 2026
Market data from TradingView’s public feed, delayed as the exchange requires. SuperCharting is charting software and gives no investment advice.